NanoString Technologies Announces Commencement of Public Offering of Common Stock
16 juil. 2018 16h15 HE
|
NanoString Technologies, Inc.
SEATTLE, July 16, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Technologies Provides Preliminary Revenue Results for Second Quarter 2018
16 juil. 2018 16h14 HE
|
NanoString Technologies, Inc.
SEATTLE, July 16, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided...
NanoString to Release Second Quarter 2018 Financial Results and Host Conference Call on Tuesday, August 7, 2018
09 juil. 2018 06h00 HE
|
NanoString Technologies, Inc.
SEATTLE, July 09, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Establishes Netherlands Cancer Institute as a Center of Excellence for Digital Spatial Profiling
18 juin 2018 08h57 HE
|
NanoString Technologies, Inc.
SEATTLE, June 18, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Announces Collaboration with National Cancer Institute to Improve Cancer Immunotherapy Biomarker Discovery
04 juin 2018 06h00 HE
|
NanoString Technologies, Inc.
SEATTLE, June 04, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Highlights Record Number of nCounter-Based Abstracts at the 2018 Annual Meeting of the American Society of Clinical Oncology
31 mai 2018 06h00 HE
|
NanoString Technologies, Inc.
More than 50 abstracts highlight the diverse capabilities of NanoString’s technologies in immuno-oncology, biomarker development and validation, and cancer characterization SEATTLE, May 31,...
NanoString to Present at the 2018 UBS Global Health Care Conference
15 mai 2018 16h01 HE
|
NanoString Technologies, Inc.
SEATTLE, May 15, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Technologies Releases Operating Results for First Quarter of 2018
08 mai 2018 16h01 HE
|
NanoString Technologies, Inc.
SEATTLE, May 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported...
NanoString to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
02 mai 2018 06h00 HE
|
NanoString Technologies, Inc.
SEATTLE, May 02, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...
NanoString Partners with Multiple Leading Contract Research Organizations to Market Digital Spatial Profiling Service
30 avr. 2018 06h00 HE
|
NanoString Technologies, Inc.
SEATTLE, April 30, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...